why choose us

First received: August 17, 2022

Clinical Trial: Tislelizumab Combined With XELOX as Perioperative Therapy for Locally Advanced Gastric Cancer

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Locally Advanced Gastric Adenocarcinoma

Study Type: Interventional


Official Title: Tislelizumab Combined With XELOX as Perioperative Therapy for Locally Advanced Gastric Cancer: A Single-center, Single-arm, Phase ? Study

Brief Summary: The effective treatment of locally advanced gastric cancer has always been a research hotspot in academia. In recent years, mainstream studies have shown that the treatment mode of locally advanced gastric cancer has changed from single surgery mode in the past, to multi-disciplinary comprehensive treatment mode for now, which is based on surgery. Several studies indicate that for most late-stage LAGC, the perioperative treatment model can further enhance the survival rates and prognosis of patients, compared with…

Read more